A high‐throughput RNAi screen for detection of immune‐checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|4|450-463

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.4, 2015-04, pp. : 450-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ADAP and SKAP55 deficiency suppresses PD‐1 expression in CD8+ cytotoxic T lymphocytes for enhanced anti‐tumor immunotherapy

By  

EMBO Molecular Medicine, Vol. 7, Iss. 6, 2015-06 ,pp. : 754-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carotid MRI Detection of Intraplaque Hemorrhage at 3T and 1.5T

By  

Journal of Neuroimaging, Vol. 25, Iss. 3, 2015-05 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary pleomorphic carcinoma with few PD‐1‐positive immune cells and regulatory T cells that showed a complete response to nivolumab

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 193-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

By  

EMBO Molecular Medicine, Vol. 7, Iss. 8, 2015-08 ,pp. : 1034-1047

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of circulating tumor cells using oHSV1‐hTERT‐GFP in lung cancer

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 44-50

John Wiley & Sons Inc

Access to resources Recommend Favorite